Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 800 shares, a decline of 20.0% from the November 15th total of 1,000 shares. Based on an average trading volume of 15,800 shares, the days-to-cover ratio is presently 0.1 days.
Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF
A hedge fund recently raised its stake in Invesco Nasdaq Biotechnology ETF stock. Mirae Asset Global Investments Co. Ltd. increased its stake in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) by 22.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 259,733 shares of the company’s stock after acquiring an additional 48,137 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned about 15.93% of Invesco Nasdaq Biotechnology ETF worth $6,156,000 at the end of the most recent reporting period.
Invesco Nasdaq Biotechnology ETF Stock Performance
Shares of NASDAQ IBBQ opened at $22.20 on Monday. The stock has a market cap of $36.19 million, a P/E ratio of 17.39 and a beta of 0.61. The firm has a 50 day moving average price of $23.31 and a two-hundred day moving average price of $23.45. Invesco Nasdaq Biotechnology ETF has a 52-week low of $20.14 and a 52-week high of $24.84.
Invesco Nasdaq Biotechnology ETF Increases Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Featured Articles
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- There Are Different Types of Stock To Invest In
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- The Most Important Warren Buffett Stock for Investors: His Own
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to buy stock: A step-by-step guide for beginnersÂ
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.